Continuing Research and Development Activities
First written in FY2017-Q1. 25 of 26 entries say "Restated". Latest entry: FY2026.
97 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The Group's total R&D expenses for the current consolidated fiscal year were ¥1,341 million, and R&D activities by segment were as follows.」
The company continued its R&D activities, recorded R&D expenses of ¥1,341 million and disclosed activities including CFCC, mooring technologies, strengthening and weight reduction. - FY2026-H1RestatedAnnual report
「Total R&D expenses for the current interim consolidated period were ¥642 million. There were no material changes in the status of the Group's R&D activities during the current interim consolidated period.」
The company recorded R&D expenses of ¥642 million and maintained its explanation that there were no material changes in the status of its R&D activities. - FY2025RestatedAnnual report
「The Group's total R&D expenses for the current consolidated fiscal year were ¥1,324 million, and R&D activities by segment were as follows.」
The company continued its R&D activities, recorded full-year R&D expenses of ¥1,324 million and disclosed R&D activities involving CFCC, wire ropes, steel cords and mooring technologies for floating offshore wind power generation. - FY2025-H1RestatedAnnual report
「Total R&D expenses for the current interim consolidated period were ¥663 million. There were no material changes in the status of the Group's R&D activities during the current interim consolidated period.」
The company recorded R&D expenses of ¥663 million and maintained its explanation that there were no material changes in the status of its R&D activities. - FY2024-Q3RestatedAnnual report
「Total R&D expenses for the third quarter of the current cumulative consolidated period were ¥894 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed R&D expenses of ¥894 million. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the third quarter of the current cumulative consolidated period were ¥935 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company maintained its explanation that there were no material changes in its R&D activities and disclosed R&D expenses of ¥935 million. - FY2023-Q2RestatedAnnual report
「Total R&D expenses for the second quarter of the current cumulative consolidated period were ¥629 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company maintained its explanation that there were no material changes in its R&D activities and disclosed R&D expenses of ¥629 million for the second quarter of the current cumulative consolidated period. - FY2022-Q3RestatedAnnual report
「Total R&D expenses for the third quarter of the current cumulative consolidated period were ¥830 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company maintained its explanation that there were no material changes in its R&D activities and disclosed R&D expenses of ¥830 million. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the second quarter of the current cumulative consolidated period were ¥548 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company maintained its explanation that there were no material changes in its R&D activities and disclosed R&D expenses of ¥548 million for the second quarter of the current cumulative consolidated period. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current cumulative consolidated period were ¥256 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company maintained its explanation that there were no material changes in its R&D activities and disclosed R&D expenses of ¥256 million. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the third quarter of the current cumulative consolidated period were ¥891 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥891 million and maintained its explanation that there were no material changes in the status of its R&D activities. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current cumulative consolidated period were ¥278 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company maintained its explanation that there were no material changes in its R&D activities and disclosed R&D expenses of ¥278 million. - FY2020RestatedAnnual report
「The Group's total R&D expenses for the current consolidated fiscal year were ¥1,234 million, and R&D activities by segment were as follows.」
The company continued its R&D activities and disclosed full-year R&D expenses of ¥1,234 million, along with activities including strengthening, weight reduction and CFCC commercialization. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the second quarter of the current cumulative consolidated period were ¥550 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company maintained its explanation that there were no material changes in its R&D activities and disclosed R&D expenses of ¥550 million. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current cumulative consolidated period were ¥289 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company maintained its explanation that there were no material changes in its R&D activities and disclosed R&D expenses of ¥289 million. - FY2019RestatedAnnual report
「The Group's total R&D expenses for the current consolidated fiscal year were ¥1,397 million, and R&D activities by segment were as follows.」
The company continued its R&D activities and disclosed full-year R&D expenses of ¥1,397 million, along with activities in each segment including strengthening, weight reduction and CFCC commercialization. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the third quarter of the current cumulative consolidated period were ¥989 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company maintained its explanation that there were no material changes in its R&D activities and disclosed R&D expenses of ¥989 million. - FY2019-Q2RestatedAnnual report
「Total R&D expenses for the second quarter of the current cumulative consolidated period were ¥628 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥628 million and maintained its explanation that there were no material changes in the status of its R&D activities. - FY2019-Q1RestatedAnnual report
「Total research and development expenses for the first quarter of the current consolidated cumulative period were ¥285 million. There were no material changes in the status of the Group’s research and development activities during the first quarter of the current consolidated cumulative period.」
The company stated that there were no material changes in its R&D activities and disclosed R&D expenses of ¥285 million for the first quarter of the current fiscal year. - FY2018RestatedAnnual report
「The Group's total R&D expenses for the current consolidated fiscal year were ¥1,363 million, and R&D activities by segment were as follows.」
The company continued its R&D activities and disclosed R&D expenses of ¥1,363 million, along with activities including strengthening wire ropes, reducing the weight of steel cords and commercializing CFCC. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the third quarter of the current cumulative consolidated period were ¥965 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥965 million and maintained its explanation that there were no material changes in the status of its R&D activities. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the second quarter of the current cumulative consolidated period were ¥606 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥606 million and maintained its explanation that there were no material changes in the status of its R&D activities. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current cumulative consolidated period were ¥322 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥322 million and maintained its explanation that there were no material changes in the status of its R&D activities. - FY2017RestatedAnnual report
「The Group's total R&D expenses for the current consolidated fiscal year were ¥1,225 million, and R&D activities by segment were as follows.」
The company continued its R&D activities and disclosed full-year R&D expenses of ¥1,225 million, along with activities including strengthening wire ropes, reducing the weight of steel cords and commercializing CFCC. - FY2017-Q2RestatedAnnual report
「Total R&D expenses for the second quarter of the current cumulative consolidated period were ¥540 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company maintained its explanation that there were no material changes in its R&D activities and disclosed R&D expenses of ¥540 million. - FY2017-Q1First statedAnnual report
「Total R&D expenses for the first quarter of the current cumulative consolidated period were ¥258 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed total R&D expenses for the quarter.